definiens: shall mean ( i ) U.S, Patent No . 4,816,567, issued March 28, 1989 from U.S. patcnt application serial no . ( USSN ) 06/483,457, and ( ii ) any claims directed to chimeric antibodies or any method of making or using chimeric antibodies, which claims are found in any patent(s ) issuing from divisionals, continuations, or continuations - in - part of any application from which U.S. Patent No . 4,816,567 claims priority, ( iii ) any claims directed to chimeric antibodies or any method of making or using chimeric antibodies, which claims are found in any patents that are reissues, reexaminations, or extensions of any of the foregoing ( i ) and ( ii ), and ( iv ) foreign counterparts of any of the foregoing ( i ), ( ii ), or ( iii ), but excluding from the foregoing ( i ), ( ii ), ( iii ) andlor ( iv ), the Liccnsed Patents, 1,05, shall mean the cost of acquisition, if purchased, or the cost of manufacture, the latter being the sum of direct production costs and manufacturing overhead costs determined in accordance with U.S, Generally Accepted Accounting Principles ( ), 1.06 . shall mean a corporation or other entity designated by and under written contract to Licensee to exercise the rights of Licensee hereunder in concert with, or in place of and to the exclusion of, Licensee in all or part ofthe Territory